Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
652.00    12.00 (1.88%)
Bid:
644.00
Ask:
660.00
Spread: 16.00 (2.484%)
Market Cap: £219.22m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

Adaptix receives CE Certification

12 May 2026 07:00

RNS Number : 8552D
Avingtrans PLC
12 May 2026
Ā 

12 May 2026

Ā 

Avingtrans plc

Ā 

("Avingtrans", the "Company", or the "Group")

Ā 

Adaptix receives CE Certification

Ā 

Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, is pleased to announce that its subsidiary Adaptix Limited ("Adaptix") has received CE certification for the Adaptix Ortho350, its breakthrough orthopaedic 3D imaging system.

Ā 

Based in the Oxford University Science Park, Adaptix is on a mission to transform radiology by offering affordable, low-dose 3D Digital Tomosynthesis (DT) imaging at the point-of-care.

Ā 

Securing CE certification demonstrates that the Adaptix Ortho350 meets the stringent safety, health and environmental protection requirements of the European Union and the United Kingdom. This enables Adaptix to commercialise its technology across key European and UK healthcare markets.

Ā 

The Adaptix Ortho350 is a compact, mobile Digital Tomosynthesis (DT) system designed to deliver fast, low dose, high resolution 3D X-ray imaging at the point of care. Developed specifically for imaging upper and lower extremities, hands, elbows, shoulders, knees and feet, at a fraction of the radiation dose of traditional CT systems and at a more reasonable cost. The Adaptix Ortho350 system provides clinicians with clearer images than 2D X-ray systems, accelerated patient workflow and enhanced diagnostic confidence.

Ā 

Adaptix already supplies its core 3D imaging technology to the veterinary and industrial nondestructive testing markets via its Adaptix VetSA3D and Adaptix NDT3D product lines. The CE certification marks a major inflection point, opening up the human imaging market for its technology in the UK and Europe paving the way for revenue expansion and strengthened commercial partnerships across the region.

Ā 

Stuart Gall, CEO of Avingtrans PLC Medical and Industrial Imaging Division, said:

"Receiving our CE certificate for the Adaptix Ortho350 is a defining moment for the company in our mission to transform radiology. This approval enables us to bring truly disruptive, low dose 3D imaging directly to clinicians and patients in the UK and Europe. For our shareholders, this milestone unlocks significant commercial opportunities and accelerates our pathway toward scaled adoption in human healthcare. We are extremely proud to move into this next phase of growth in delivering "3D-First" enhanced orthopaedic DT imaging across Primary Care, Emergency Departments and Outpatient settings."

Ā 

- ENDS -

Enquiries:

Avingtrans plc

013 5469 2391

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

Ā 

Ā 

Singer Capital MarketsĀ (Nominated Adviser and Broker)

020 7496 3000

Shaun Dobson

Alex Bond

Ā 

Ā 

IFC Advisory (Financial PR)

Ā 

020 3934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

Ā 

Ā 

Ā 

About Adaptix Ltd

Adaptix Ltd is a UK-based innovator transforming radiology with portable, low dose 3D X-ray imaging that delivers richer diagnostic insight at the point of care. Using digital tomosynthesis, the Adaptix imaging systems provide 3D visualization at doses and costs comparable to traditional 2D X-ray, supporting applications across medical, veterinary, and industrial sectors. Adaptix's mission is to make advanced imaging accessible anytime, anywhere, reshaping diagnostic pathways and enabling faster, more confident decision-making.

Adaptix Ortho350 Imaging Systems

Ā 

Adaptix's orthopaedic 3D imaging solution provides rapid, low dose, point of care diagnostics for extremities, offering clearer multi-layer views than traditional 2D X-ray. The portable system enhances diagnostic accuracy, speeds decision-making, and supports weightbearing imaging, helping clinicians deliver faster, more confident fracture and joint assessments.

Ā 

More information on Adaptix Ltd and 3D imaging technology can be found by visiting their website: www.adaptix.com

Ā 

AboutĀ Avingtrans plc:Ā 

Ā 

AvingtransĀ designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide.Ā 

Ā 

Business units

Ā 

Hayward Tyler - Luton, East Kilbride UK, USA, China and India

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments.Ā 

Energy Steel, Inc - Rochester Hills, Michigan, USA

Provider of custom fabrications for the nuclear industry, specialising in: OEM parts obsolescence; custom fabrications; engineering design solutions; product refurbishment; on-site technical support.Ā 

Stainless Metalcraft Ltd - Chatteris, UK

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems.Ā 

Booth Industries - Bolton, UK

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast and explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above.

Ormandy Group - Bradford, UK

Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products.

Slack & Parr - Kegworth, UK, USA & China

Design, manufacture and servicing of high-precision gear metering pumps, hydraulics flow dividers and industrial pumps.

Composite Products Ltd -Ā Buckingham, UK

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

Adaptix Ltd - Oxford, UK

Adaptix has developed novel 3D X-ray for Orthopaedic and Veterinary applications amongst others. Commercialisation of this system (and others) is on-going.

Magnetica Ltd - Brisbane, Australia

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units:Ā 

Scientific Magnetics - Abingdon, UK

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments.

Tecmag Inc - Houston, USA

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
MSCFZGMKKMRGVZM
Date   Source Headline
24th Sep 20101:00 pmPRNDirector/PDMR Shareholding
24th Sep 201012:09 pmPRNGrant of Options
8th Sep 20107:00 amPRNFinal Results
7th Sep 20107:00 amPRNAerospace Contract Wins
6th Sep 20107:00 amPRNContract Win
26th Jul 20107:00 amPRNChange of Adviser
7th Jul 201010:13 amPRNHolding(s) in Company
2nd Jul 20107:00 amRNSContract Win
15th Jun 20107:00 amPRNTrading Update
1st Apr 20107:00 amPRNGBP8m Contract Win and Award Win
19th Mar 20102:52 pmPRNDirector/PDMR Shareholding
19th Mar 20107:00 amPRNTrading Statement
17th Mar 20107:30 amPRNHolding(s) in Company
18th Feb 201011:28 amPRNHolding(s) in Company
10th Feb 20102:59 pmPRNDirector/PDMR Shareholding
10th Feb 20107:00 amPRNHalf-yearly Report
27th Jan 20107:00 amPRNContract Win - Aerospace Division
15th Oct 200910:56 amPRNResult of AGM
6th Oct 20097:00 amRNSNew Contract Award
9th Sep 20097:03 amPRNDirectorate Change
9th Sep 20097:00 amPRNFinal Results
11th Aug 20097:00 amRNSContract Extension
5th Aug 20099:14 amRNSNotice of Results
17th Jul 20093:01 pmRNSSettlement of Claim
8th Jul 20093:10 pmRNSGrant of Options
7th Jul 20095:03 pmRNSTotal Voting Rights
8th Jun 200912:48 pmRNSHolding(s) in Company
29th May 20097:00 amRNSAdditional Listing
27th Apr 200910:48 amRNSDirector/PDMR Shareholding
10th Feb 20097:00 amRNSHalf Yearly Report
6th Feb 20097:00 amRNSNotice of Results
26th Jan 20097:00 amRNSContract Win
31st Oct 20087:00 amRNSTotal Voting Rights
22nd Oct 20083:13 pmRNSHolding(s) in Company
22nd Oct 20083:07 pmRNSHolding(s) in Company
22nd Oct 20083:01 pmRNSHolding(s) in Company
22nd Oct 20082:18 pmRNSHolding(s) in Company
20th Oct 20083:39 pmRNSHolding(s) in Company
20th Oct 20083:21 pmRNSHolding(s) in Company
17th Oct 20081:37 pmRNSHolding(s) in Company
16th Oct 200811:06 amPRNResult of AGM and EGM
7th Oct 20087:00 amRNSRe Board Appointment
17th Sep 20087:00 amRNSIssue of Equity
10th Sep 20087:00 amPRNFinal Results
3rd Sep 20087:00 amPRNNotice of Results
2nd Sep 20087:00 amPRNMajor Contract Win with Rolls-Royce
19th Aug 20087:00 amPRNBoard Appointment
4th Jul 20081:06 pmRNSHolding(s) in Company
24th Apr 20084:35 pmRNSDirectorate Change
28th Mar 20083:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.